Want to join the conversation?
Drugmaker $AGN reported a wider 2Q16 loss as results were impacted by loss of exclusivity on Namenda IR. Net loss widened to $571.3MM or $1.44 per share from $312.7MM or $0.80 per share last year. Revenue grew to $3.68Bil from $3.63Bil, on strong performance in key brands and new product launches. Non-GAAP EPS slid to $3.35 from $3.67.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!